Literature DB >> 20541553

Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death.

Anurag Kumar Gupta1, Manjunath B Joshi, Maria Philippova, Paul Erne, Paul Hasler, Sinuhe Hahn, Therese J Resink.   

Abstract

Neutrophil interaction with activated endothelial cells (EC) is required for transmigration. We examined consequences of this interaction on NETosis. Co-culture of activated EC with neutrophils induced neutrophil extracellular trap (NET) formation, which was partially dependent on production of IL-8 by activated EC. Extended neutophil/EC co-culture resulted in EC damage, which could be abrogated by inclusion of either diphenyleneiodonium to inhibit the NAPDH oxidase pathway required for NETosis, or DNAse to disrupt NETs. These findings offer new insight into mechanisms whereby NETs trigger damage to the endothelium in sepsis, small vessel vasculitis and possibly the villous trophoblast in preeclampsia. Copyright 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541553     DOI: 10.1016/j.febslet.2010.06.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  189 in total

Review 1.  Immunopathology of mastitis: insights into disease recognition and resolution.

Authors:  Stacey L Aitken; Christine M Corl; Lorraine M Sordillo
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-09-22       Impact factor: 2.673

Review 2.  Neutrophils in the pathogenesis and manifestations of SLE.

Authors:  Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

3.  Statins enhance formation of phagocyte extracellular traps.

Authors:  Ohn A Chow; Maren von Köckritz-Blickwede; A Taylor Bright; Mary E Hensler; Annelies S Zinkernagel; Anna L Cogen; Richard L Gallo; Marc Monestier; Yanming Wang; Christopher K Glass; Victor Nizet
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 4.  Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.

Authors:  M Wigren; J Nilsson; M J Kaplan
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 5.  The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas.

Authors:  Laura Annaratone; Eliano Cascardi; Elena Vissio; Ivana Sarotto; Ewa Chmielik; Anna Sapino; Enrico Berrino; Caterina Marchiò
Journal:  Pathobiology       Date:  2020-04-23       Impact factor: 4.342

6.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

Review 7.  Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).

Authors:  Brice Korkmaz; Adam Lesner; Stephanie Letast; Yassir K Mahdi; Marie-Lise Jourdan; Sandrine Dallet-Choisy; Sylvain Marchand-Adam; Christine Kellenberger; Marie-Claude Viaud-Massuard; Dieter E Jenne; Francis Gauthier
Journal:  Semin Immunopathol       Date:  2013-02-06       Impact factor: 9.623

Review 8.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 9.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

10.  In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.

Authors:  He Meng; Srilakshmi Yalavarthi; Yogendra Kanthi; Levi F Mazza; Megan A Elfline; Catherine E Luke; David J Pinsky; Peter K Henke; Jason S Knight
Journal:  Arthritis Rheumatol       Date:  2017-03       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.